Patents Assigned to Bioexpertise, LLC
  • Method for use of IGF-binding protein for selective sensitization of target cells in vivo
    Patent number: 7371813
    Abstract: New methods for the treatment of human disease are provided. IGFBP-3 is administered together with a co-administered agent to subjects having disease, thereby alleviating the symptoms of the disease, under conditions where administration of IGFBP-3 alone at the maximum practicable dose has no measurable beneficial effect on the disease condition.
    Type: Grant
    Filed: February 13, 2004
    Date of Patent: May 13, 2008
    Assignee: Bioexpertise LLC
    Inventor: Desmond Mascarenhas
  • Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
    Publication number: 20070128113
    Abstract: The present invention is related to methods of delivering MBD peptide-linked agents into live cells. The methods described herein comprise contacting MBD peptide-linked agents to live cells under a condition of cellular stress. The methods of the invention may be used for therapeutic or diagnostic purposes.
    Type: Application
    Filed: April 14, 2006
    Publication date: June 7, 2007
    Applicant: BIOEXPERTISE LLC
    Inventors: Desmond Mascarenhas, Baljit Singh
  • IGF-binding protein-derived peptide or small molecule
    Publication number: 20050209155
    Abstract: New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.
    Type: Application
    Filed: January 6, 2005
    Publication date: September 22, 2005
    Applicant: BIOEXPERTISE LLC
    Inventor: Desmond Mascarenhas
  • IGF-binding protein-derived peptide or small molecule
    Patent number: 6914049
    Abstract: New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: July 5, 2005
    Assignee: Bioexpertise, LLC
    Inventor: Desmond Mascarenhas
  • IGF-binding protein-derived peptide
    Patent number: 6887851
    Abstract: New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: May 3, 2005
    Assignee: Bioexpertise, LLC
    Inventor: Desmond Mascarenhas
  • IGF-binding protein-derived peptide
    Patent number: 6861406
    Abstract: New compositions based on IGF-binding protein sequences are provided. New tools for high-throughput research are provided. New methods for the treatment of human disease are provided. IGFBP-3-derived peptide or small molecule is administered to subjects having disease, thereby alleviating the symptoms of the disease.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: March 1, 2005
    Assignee: Bioexpertise, LLC
    Inventor: Desmond Mascarenhas